| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/16/2008 | CN101219204A Combinations comprising a low molecular weight thrombin inhibitor and a prodrug of a low molecular weight thrombin inhibitor |
| 07/16/2008 | CN101219112A Compound anticancer sustained-release injection containing bendamustine |
| 07/16/2008 | CN100402660C Product quality enhancement in mammalian cell culture processes for protein production |
| 07/16/2008 | CN100402654C Method of treating ischemic disease |
| 07/16/2008 | CN100402648C Human Nanog gene and its encoded protein and application |
| 07/16/2008 | CN100402580C Modified bio-related substance, process for producing the same, and intermediate |
| 07/16/2008 | CN100402552C Antibiotic peptide and its code sequence and use |
| 07/16/2008 | CN100402549C Bridged bicyclic serine protease inhibitors |
| 07/16/2008 | CN100402548C Method for preparing physiological active polypeptide of deer placenta |
| 07/16/2008 | CN100402096C Dry hemostatic compositions and methods for their preparation |
| 07/16/2008 | CN100402089C Angiotensin-converting enzyme inhibitory peptides |
| 07/16/2008 | CN100402088C Method for preparing low molecular weighted glucidamin collagen composition, and its product |
| 07/16/2008 | CN100402087C Lyophilized suspended powder injection and preparation method thereof |
| 07/16/2008 | CN100402086C Slow released nano microsphere gel of alkaline fibroblast growth factor and polylactic acid and its preparing method |
| 07/16/2008 | CN100402085C Production of high-concentration thymic peptide solution and large-specification thymic peptide preparation |
| 07/16/2008 | CN100402084C Method for detection or quantitative determination of metabolite of fentanyl or metabolite of fentanyl analogues and kit |
| 07/16/2008 | CN100401896C Methods of diagnosis and treatment of interstitial lung disease |
| 07/15/2008 | US7399901 linker for activation of T- cells (lat genes and proteins), used for screening drug useful for treatment against asthma and allergies |
| 07/15/2008 | US7399878 Pharmaceutical compounds |
| 07/15/2008 | US7399849 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 07/15/2008 | US7399848 Polynucleotides encoding growth differentiation factor-8 |
| 07/15/2008 | US7399839 soluble proteins containing free cysteine residues and having increased efficiency |
| 07/15/2008 | US7399833 Glycosylated megakaryocyte growth and differentiation factor, therapy |
| 07/15/2008 | US7399831 Promotes the growth and differentiation of cells; attached therapeutic agents can be used to promote this process and the gel along with the growing cells can be implanted at a site in vivo where tissue repair is needed; membranes can be used for culturing cells in vitro; delivering drugs in vitro |
| 07/15/2008 | US7399829 Variants of RANKL protein |
| 07/15/2008 | US7399828 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/15/2008 | US7399827 For diagnosis and for vaccine based therapy of neoplasms of prostate, testis and uterus; inhibiting the growth of malignant cells expressing PAGE-4, and methods of inducing an enhanced immune response to PAGE-4-expressing cancers |
| 07/15/2008 | US7399826 Promoting union of bone tissue in fracture, promoting bone growth in spinal fusion, or promoting bone growth in therapy for osteoporosis; 13-amino acid polypeptide |
| 07/15/2008 | US7399825 Synthetic peptide, inhibitor to DNA viruses |
| 07/15/2008 | US7399823 Antimicrobial theta defensins and methods of using same |
| 07/15/2008 | US7399787 Methods of treating cancer with HDAC inhibitors |
| 07/15/2008 | US7399750 Methods for cardiac gene transfer |
| 07/15/2008 | US7399749 For therapy and prophylaxis of disorders associated with the HCV protease |
| 07/15/2008 | US7399747 Peptides carrying substances across the blood brain barrier |
| 07/15/2008 | US7399746 Fragments of alpha-1 proteinase inhibitor (API) or chimeric proteins of API and insulin-like growth factor for use in stimulating wound healing |
| 07/15/2008 | US7399745 polypeptides, fragments and/or variants, used for treatment of metabolic disorders, such as diabetes and obesity; hypoglycemic agents |
| 07/15/2008 | US7399744 Methods for affecting body composition |
| 07/15/2008 | US7399743 Targeted thrombosis |
| 07/15/2008 | US7399742 Anti-osteolytic therapy involving adiponectin |
| 07/15/2008 | US7399741 Notch |
| 07/15/2008 | US7399740 Poly-Glu,Tyr for neuroprotective therapy |
| 07/15/2008 | US7399739 Vertebral augmentation composition and method |
| 07/15/2008 | US7399613 Sialic acid nucleotide sugars |
| 07/15/2008 | US7399612 VEGF-binding fusion proteins and nucleic acids encoding the same |
| 07/15/2008 | US7399605 Generating preferential polymerase in sample; obtain nucleotide sequences, incubate in reaction mixture, translate nucleotide sequences, recover polypeptide |
| 07/15/2008 | US7399595 Means for the diagnosis and therapy of CTCL |
| 07/15/2008 | US7399593 Member of the TNF ligand family |
| 07/15/2008 | US7399586 Modulation of biological signal transduction by RNA interference |
| 07/15/2008 | US7399489 Exendin analog formulations |
| 07/15/2008 | US7399486 Continuously introducing the mixed fluids into a dryer from the two or more different fluids for preparation of sustained release microspheres containing a biodegradable polymer, a drug, an additive and a solvent with different types of contents or both of the components, by controlling the mixing ratios |
| 07/15/2008 | US7399476 Nucleic acid free ghost preparations |
| 07/15/2008 | US7399473 Virus coat protein/receptor chimeras and method of use |
| 07/15/2008 | US7399471 Diagnosis of RH factor; using polypeptides to form antibodies; purified polypeptide capable of forming antigen binding structures with specificity for Rhesus D antigens for treating idiopathic thrombocytopenic purpura (ITP) or mistransfusion of Rhesus incompatible blood |
| 07/15/2008 | US7399466 Osteocalcin; enzyme inhibitors; promote bone, teeth growth; administering Dna gene |
| 07/15/2008 | US7399465 Pharmaceutical compositions for treating arthritis and inflammatory disease |
| 07/15/2008 | US7399464 Polypeptides of the IFNα-7 gene |
| 07/15/2008 | US7399463 HSA-free formulations of interferon-beta |
| 07/15/2008 | CA2315258C Neuroprotective agents |
| 07/15/2008 | CA2299049C Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
| 07/15/2008 | CA2289086C Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells |
| 07/15/2008 | CA2274149C Peptides and compounds that bind to a receptor |
| 07/15/2008 | CA2271857C Method for treating symptoms of diabetes |
| 07/15/2008 | CA2250861C Cyclic adhesion inhibitors |
| 07/15/2008 | CA2250630C Novel lantibiotic related to actagardine, and processes for the preparation and use thereof |
| 07/15/2008 | CA2225398C Pharmaceutical composition comprising albumin as an active ingredient |
| 07/15/2008 | CA2207103C Methods to identify hemochromatosis |
| 07/15/2008 | CA2205557C Monofunctional and/or polyfunctional polylysine conjugates |
| 07/15/2008 | CA2156083C Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals |
| 07/15/2008 | CA2149329C Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 07/15/2008 | CA2144185C Method of prophylaxis of acute renal failure |
| 07/15/2008 | CA2142370C T cell epitopes of ryegrass pollen allergen |
| 07/15/2008 | CA2113023C Tnf receptor promoter |
| 07/10/2008 | WO2008083302A2 Use of adenosine deaminase for treating pulmonary disease |
| 07/10/2008 | WO2008083290A1 Romidepsin-based treatments for cancer |
| 07/10/2008 | WO2008083157A2 Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject |
| 07/10/2008 | WO2008082721A2 Polymer-stabilized liposomal compositions and methods of use |
| 07/10/2008 | WO2008082656A1 Glp-1 pharmaceutical compositions |
| 07/10/2008 | WO2008082608A2 Interleukin-15 antagonists for the treatment of anemia |
| 07/10/2008 | WO2008082563A2 Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents |
| 07/10/2008 | WO2008082274A1 An insulinotropic complex using an immunoglobulin fragment |
| 07/10/2008 | WO2008082182A1 A composition containing arazyme for the prevention and treatment of cancer |
| 07/10/2008 | WO2008082019A1 Pharmaceutical composition containing arazyme for the prevention of liver dysfunction |
| 07/10/2008 | WO2008081812A1 Anti-tumor peptide and use thereof |
| 07/10/2008 | WO2008081701A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 07/10/2008 | WO2008081024A1 Subcutaneous administration of coagulation factor viia-related popypeptdes |
| 07/10/2008 | WO2008081013A1 Use of somatostatin analogs in cluster headache |
| 07/10/2008 | WO2008080989A1 Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof |
| 07/10/2008 | WO2008080956A1 Prognostic molecular markers for the cancer therapy with aplidine |
| 07/10/2008 | WO2008080333A1 Compound preparation for enhancing memory |
| 07/10/2008 | WO2008080302A1 NEW SCHEME OF COMBINING CYTOKINE FUSION PROTEIN (IL-2/Fc) AND TRADITIONAL CHINESE MEDICINE COMPOUND 861 FOR ENHANCING IMMUNE RESPONSE OF HEPATITIS B VACCINE AND BREAKING IMMUNE TOLERANCE OF HEPATITIS B VIRUS |
| 07/10/2008 | WO2008080291A1 Poly(glutamic acid)-drug conjugate with an amino acid as a linker |
| 07/10/2008 | WO2008080194A1 Pain-relieving compositions and uses therefor |
| 07/10/2008 | WO2008061192A3 Stabilized maml peptides and uses thereof |
| 07/10/2008 | WO2008058942A3 Method of cell culture and method of treatment comprising a vepo protein variant |
| 07/10/2008 | WO2008058679A3 Novel amides acting on the adenosine receptors |
| 07/10/2008 | WO2008050362A3 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies |
| 07/10/2008 | WO2008033887A3 Methods for treating cancer |
| 07/10/2008 | WO2008020744A3 Method for extracting the nerve tissue growth factor from v.lebetina linnaeus venom |
| 07/10/2008 | WO2008020743A3 Method for extracting a platelet aggregation inhibitor from agkistrodon blomhoffii ussuriensis venom |
| 07/10/2008 | WO2008020742A3 Method for extracting fibrinogenic/fibrinolytic protein from agkistrodon blomhoffii ussuriensis venom |